EP1888578
2-Metýl-2-[4-(3-metýl-2-oxó-8-kínólín-3-ýl-2,3-díhýdró-imídasó[4,5-c]kínólínýl)-fenýl]própíónítríl sem lípíðkínasahindri
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.5.2006EP published:
30.11.2011EP application number:
06753710.0
EP translation filed:
23.1.2012Grant published:
15.2.2012EPO information:
European Patent Register
Max expiry date:
17.5.2026Expiry date:
17.5.2017
Title:
2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO [4,5-C] QUINOLINYL)-PHENYL]PROPIONITRILE AS LIPID KINASE INHIBITOR
Timeline
Today
18.5.2006EP application
30.11.2011EP Publication
23.1.2012Translation submitted
15.2.2012Registration published
17.5.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
GARCIA-ECHEVERRIA, CarlosAddress:
Basel, CH
Name:
STAUFFER, FrédéricAddress:
Reinach, CH
Name:
FURET, PascalAddress:
Thann, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0510390Date:
20.5.2005Country:
GB
Classification
Categories:
C07D 471/04, A61K 31/4188, A61P 35/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.4.2012
Expires: 17.5.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 9.4.2013
Expires: 17.5.2014
Payer: Árnason Faktor
Number: 9
Paid: 9.4.2014
Expires: 17.5.2015
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2015
Expires: 17.5.2016
Payer: Árnason Faktor
Number: 11
Paid: 12.4.2016
Expires: 17.5.2017
Payer: Árnason Faktor